Showing results (131-140 of 277) with videos related to
Sort By:
Pageof 28
Cardiovascular Research|August 6, 2002
Mitochondrial K(ATP) channels: role in cardioprotectionOlaf Oldenburg, Michael V Cohen, Derek M Yellon, et al.Journal of Cellular and Molecular Medicine|June 11, 2009
Preconditioning the diabetic human myocardiumVivek Sivaraman, Derek J Hausenloy, Abigail M Wynne, et al.American Journal of Physiology. Heart and Circulatory Physiology|September 11, 2004
Ischemic preconditioning protects by activating prosurvival kinases at reperfusionDerek J Hausenloy, A Tsang, Mihaela M Mocanu, et al.Circulation Research|July 10, 2004
Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathwayAndrew Tsang, Derek J Hausenloy, Mihaela M Mocanu, et al.American Journal of Physiology. Heart and Circulatory Physiology|June 18, 2005
Mitochondrial permeability transition pore as a target for cardioprotection in the human heartSelvaraj Shanmuganathan, Derek J Hausenloy, Michael R Duchen, et al.Journal of Cardiovascular Pharmacology and Therapeutics|September 11, 2015
Characterization of the Langendorff Perfused Isolated Mouse Heart Model of Global Ischemia-Reperfusion Injury: Impact of Ischemia and Reperfusion Length on Infarct Size and LDH ReleaseXavier Rossello, Andrew R Hall, Robert M Bell, et al.Scientific Reports|October 10, 2020
Neuroprotection by remote ischemic conditioning in the setting of acute ischemic stroke: a preclinical two-centre studyMaryna V Basalay, Marlene Wiart, Fabien Chauveau, et al.Cardiovascular Research|July 28, 2014
HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition poreSang-Ging Ong, Won Hee Lee, Louise Theodorou, et al.Cardiovascular Research|August 6, 2002
Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?Derek J Hausenloy, Helen L Maddock, Gary F Baxter, et al.Journal of Cardiovascular Pharmacology and Therapeutics|December 25, 2012
Glimepiride treatment facilitates ischemic preconditioning in the diabetic heartDerek J Hausenloy, Abigail M Wynne, Mihaela M Mocanu, et al.Pageof 28